Showing results (1051-1060 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|November 21, 2017
Crosstalk of LKB1- and PTEN-regulated signals in liver morphogenesis and tumor developmentChengyou Jia, Vivian Medina, Chenchang Liu, et al.
Hepatology Communications|November 9, 2019
Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein CholesterolChristian Labenz, Jürgen H Prochaska, Yvonne Huber, et al.
Hepatology Communications|December 14, 2019
Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate EndpointsNaim Alkhouri, Rohit Kohli, Ariel E Feldstein
Hepatology Communications|December 14, 2019
A Pilot Genome-Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASHSamer Gawrieh, Xiuqing Guo, Jingyi Tan, et al.
Hepatology Communications|May 27, 2022
The unfolded protein response to PI*Z alpha-1 antitrypsin in human hepatocellular and murine modelsYuanqing Lu, Liqun R Wang, Jungnam Lee, et al.
Hepatology Communications|May 31, 2022
Improved prognosis of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antiviralsTsuyoshi Fukumoto, Tatsuya Minami, Makoto Moriyama, et al.
Hepatology Communications|December 18, 2018
Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver TransplantationMaria G Cardona-Gonzalez, Jason D Goldman, Lawrence Narayan, et al.
Hepatology Communications|December 18, 2018
Multitarget Direct-Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C VirusShikha Shrivastava, Manasa Bhatta, Haley Ward, et al.
Hepatology Communications|December 18, 2018
Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-.Leiden MiceMartine C Morrison, Lars Verschuren, Kanita Salic, et al.
Hepatology Communications|December 18, 2018
Prohibitin 1 Acts As a Negative Regulator of Wingless/Integrated-Beta-Catenin Signaling in Murine Liver and Human Liver Cancer CellsNirmala Mavila, Yuanyuan Tang, Joshua Berlind, et al.
Pageof 179